Skin Elements Limited (ASX:SKN)
Australia · Delayed Price · Currency is AUD
0.0050
+0.0010 (25.00%)
At close: Mar 27, 2026
Revenue by Segment
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | Jun '18 Jun 30, 2018 | Jun '17 Jun 30, 2017 | Jun '16 Jun 30, 2016 |
|---|
Biotechnology sector focused on developing of its proprietary SE Formula | 469.96K | 416.20K | 194.13K | - | - | | | | | |
Biotechnology sector focused on developing of its proprietary SE Formula Growth | 12.92% | 114.39% | - | - | - | | | | | |
| - | - | - | 1.41M | 288.74K | | | | | |
| - | - | - | 387.75% | -32.09% | | | | | |
| 469.96K | 416.20K | 194.13K | 1.41M | 288.74K | | | | | |
| 12.92% | 114.39% | -86.22% | 387.75% | -32.09% | | | | | |
Revenue by Geography
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | Jun '18 Jun 30, 2018 | Jun '17 Jun 30, 2017 | Jun '16 Jun 30, 2016 |
|---|
| 469.96K | 416.20K | 194.13K | 1.41M | 288.74K | | | | | |
| 12.92% | 114.39% | -86.22% | 387.75% | -32.09% | | | | | |
| 469.96K | 416.20K | 194.13K | 1.41M | 288.74K | | | | | |
| 12.92% | 114.39% | -86.22% | 387.75% | -32.09% | | | | | |
Source: S&P Global Market Intelligence.
